Survival and Response Outcomes for Gastrointestinal Neuroendocrine Tumor (GEP-NETs) Patients Treated with Lutetium—177-DOTATATE in a Brazilian Reference Center: A Six-Year Follow-Up Experience

Survival and Response Outcomes for Gastrointestinal Neuroendocrine Tumor (GEP-NETs) Patients Treated with Lutetium—177-DOTATATE in a Brazilian Reference Center: A Six-Year Follow-Up Experience

Background: PRRT can be an option for all-grade GEP-NETs, but selecting patients is challenging. In this scenario, clinical-pathological and radiological characteristics, such as pre-treatment Ga-68 DOTA PET/CT, might have the potential to help. Methods: A retrospective chart review was conducted on...

Full description

Bibliographic Details
Main Authors: Zenaide Silva de Souza, Camila Bragança Xavier, Luciana Beatriz Mendes Gomes, Maria Fernanda Barbosa de Medeiros, Micelange Carvalho de Sousa, Allan Andresson Lima Pereira, José Flávio Gomes Marin, Carlos Alberto Buchpiguel, Frederico Perego Costa
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Cancers
Subjects:
neuroendocrine tumors
lutetium-177
nuclear medicine
Online Access:https://www.mdpi.com/2072-6694/15/18/4506

Internet

https://www.mdpi.com/2072-6694/15/18/4506

Similar Items